← back to search

Carsten Kamphues

Park-Klinik Weißensee ·
Area of research
Oncology · Hepatology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research, and Cholangiocarcinoma and Gallbladder Cancer Studies.
h-index
31
citations
4,996
works
127
NIH funding
primary concept
email

Recent publications

Role of visceral fat on postoperative complications and relapse in patients with Crohn's disease after ileocecal resection: Is it overrated?
International Journal of Colorectal Disease 2024cited by 6position: middledoi
Stepwise Analysis of Resection Margin Impact on Survival and Distant Metastasis in Pancreatic Head Ductal Adenocarcinoma
International Journal of Surgical Pathology 2024cited by 1position: middledoi
Diagnostic performance of Node Reporting and Data System (Node-RADS) for regional lymph node staging of gastric cancer by CT
European Radiology 2023cited by 50position: middledoi
cCPE Fusion Proteins as Molecular Probes to Detect Claudins and Tight Junction Dysregulation in Gastrointestinal Cell Lines, Tissue Explants and Patient-Derived Organoids
Pharmaceutics 2023cited by 12position: middledoi
The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
International Journal of Molecular Sciences 2023cited by 11position: middledoi
Feasibility of in vivo magnetic resonance elastography of mesenteric adipose tissue in Crohn’s disease
Quantitative Imaging in Medicine and Surgery 2023cited by 10position: middledoi
Ex vivo magnetic resonance elastography of the small bowel in Crohn’s disease
Quantitative Imaging in Medicine and Surgery 2023cited by 3position: middledoi
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases
JAMA Surgery 2022cited by 35position: middledoi
Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease
International Journal of Colorectal Disease 2022cited by 14position: middledoi
Diagnostic Accuracy of Magnetic Resonance Enterography for the Evaluation of Active and Fibrotic Inflammation in Crohn’s Disease
Frontiers in Surgery 2022cited by 9position: middledoi
Mitogen‐activated protein kinase activity drives cell trajectories in colorectal cancer
EMBO Molecular Medicine 2021cited by 200position: middledoi
Feasibility of Intestinal<scp>MR</scp>Elastography in Inflammatory Bowel Disease
Journal of Magnetic Resonance Imaging 2021cited by 24position: middledoi
Risk factors for upper and lower type prolonged postoperative ileus following surgery for Crohn’s disease
International Journal of Colorectal Disease 2021cited by 18position: middledoi
Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging
Biology 2021cited by 9position: lastdoi
Survival rates and prognostic factors in right- and left-sided colon cancer stage I–IV: an unselected retrospective single-center trial
International Journal of Colorectal Disease 2021cited by 7position: lastdoi
Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma
Cancers 2021cited by 6position: lastdoi
Accuracy of various criteria for lymph node staging in ductal adenocarcinoma of the pancreatic head by computed tomography and magnetic resonance imaging
World Journal of Surgical Oncology 2020cited by 36position: lastdoi
Stapled intestinal anastomoses are more cost effective than hand-sewn anastomoses in a diagnosis related group system
The Surgeon 2020cited by 17position: middledoi
Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 15position: middledoi
Association of <i>BRAF</i> Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
JAMA Surgery 2018cited by 203position: middledoi
Ataxia-telangiectasia–Mutated Protein Kinase Levels Stratify Patients With Pancreatic Adenocarcinoma Into Prognostic Subgroups With Loss Being a Strong Indicator of Poor Survival
Pancreas 2014cited by 12position: firstdoi
Preliminary experience with CT‐guided high‐dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma
HPB 2012cited by 12position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Katharina Beyer · Augsburg University13 papers (2020–2024)Florian N. Loch · Humboldt-Universität zu Berlin12 papers (2020–2024)Christian Schineis · Charité - Universitätsmedizin Berlin10 papers (2020–2024)Johannes C. Lauscher · Augsburg University9 papers (2020–2024)Martin E. Kreis · Charité - Universitätsmedizin Berlin8 papers (2018–2024)Georgios Antonios Margonis · Memorial Sloan Kettering Cancer Center7 papers (2018–2024)Rolf Reiter · Humboldt-Universität zu Berlin5 papers (2021–2023)Benjamin Weixler · Humboldt-Universität zu Berlin5 papers (2020–2024)Ioannis Pozios · Humboldt-Universität zu Berlin4 papers (2021–2024)Patrick Asbach · Humboldt-Universität zu Berlin4 papers (2020–2023)Wael Rayya · Charité - Universitätsmedizin Berlin4 papers (2021–2024)Claudius E. Degro · Charité - Universitätsmedizin Berlin4 papers (2020–2021)Simon Schallenberg · German Cancer Research Center4 papers (2021–2024)Frederick Klauschen · Institute of Clinical Cancer Research4 papers (2014–2024)David Horst · German Cancer Research Center4 papers (2020–2024)Bernd Hamm · Freie Universität Berlin3 papers (2021–2023)Claudia Seifarth · Humboldt-Universität zu Berlin3 papers (2021–2024)Andrea Stroux · Humboldt-Universität zu Berlin3 papers (2020–2022)Philip Bischoff · German Cancer Research Center3 papers (2020–2023)Mihnea P. Dragomir · German Cancer Research Center3 papers (2021–2024)